NIOX Group Plc (CSSPF)

Market Cap	371.79M +25.3%
Revenue (ttm)	63.02M +21.4%
Net Income	7.12M -53.6%
EPS	0.02 -51.6%
Shares Out	n/a
PE Ratio	52.19
Forward PE	23.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	17,166
Open	0.9200
Previous Close	0.6900
Day's Range	0.9200 - 0.9200
52-Week Range	0.6900 - 0.9200
Beta	-0.18
RSI	74.90
Earnings Date	Apr 2, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. N...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 91
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSSPF

Financial Performance

In 2024, NIOX Group's revenue was 41.80 million, an increase of 13.59% compared to the previous year's 36.80 million. Earnings were 3.70 million, a decrease of -65.42%.

Financial numbers in GBP